Introduction
Patents promote innovation by granting monopoly in exchange for disclosure of the invention. However, not every invention matures into a grantable or enforceable patent. Among the legal requirements that determine whether a patent can be granted, two requirements are crucial globally: enablement (requires sufficient teaching such that a skilled practitioner can make and use the invention without undue experimentation) and written description (requires that what is claimed aligns with what the inventor actually disclosed or possessed as of the filing date).
In practice, mastering these requirements determines whether the patent stands scrutiny or crumbles during examination or litigation. Together, they ensure that the monopoly sought by a patent applicant is justified by a commensurate public disclosure of the invention. This balance underpins the patent bargain: the grant of exclusive rights in exchange for enabling the public to practice the invention once the patent expires.
While the concepts of enablement and written description share an underlying objective of preventing speculative claiming, they are applied through separate statutory provisions and legal tests. For practitioners, inventors, and patent examiners alike, understanding how these requirements are applied in Australia and how they interact with parallel common law jurisdictions such as the UK, New Zealand, and, by analogy, the US is essential for effective patent drafting and prosecution.
In Australia, these requirements are codified under the Patents Act 1990. Section 40(2)(a) requires that the complete specification “disclose the invention in a manner which is clear enough and complete enough for the invention to be performed by a person skilled in the relevant art”. This is the primary “enablement” provision. Section 40(2)(aa) requires that the specification must “disclose the best method known to the applicant of performing the invention”. While distinct from enablement, failure to disclose the best method can result in invalidity even if enablement is otherwise satisfied. Further, Section 40(3) mandates that the claims be “supported by matter disclosed in the specification”. The “support” requirement embodies the written description principle i.e., the claims must not extend beyond what is actually disclosed.
The 2013 Raising the Bar reforms elevated these requirements, bringing Australia in closer alignment with UK/EPO practice and tightening the disclosure burden, especially for functional or broadly claimed inventions. The Australian courts have consistently stressed that enablement must be assessed across the full width of the claims. For instance, in Lockwood Security Products Pty Ltd v Doric Products Pty Ltd (2007) 235 CLR 173, the High Court confirmed that enablement requires the specification to enable the skilled person to produce substantially all embodiments within the claims without undue burden.
Further, recent decisions from Australian courts and the Patent Office underscore the ongoing importance of clear enablement, written description, and best method disclosure. In Zoetis Services LLC v Boehringer Ingelheim Animal Health USA Inc [2024], the Full Court of the Federal Court invalidated vaccination patents for failure to disclose the best method, specifically, omitting the antigen concentrations that had been used in successful formulations. This case illustrates that non-disclosure of such technical detail can be fatal to patent validity. Similarly, in CQMS Pty Ltd v ESCO Group LLC [2025], a claim to a wear member having “a hole configured to secure a lock” lacked support because the specification described only extendable or folding locks, while the claimed scope extended to all locking types.
The same reasoning applied in Dyson Technology Ltd v Jemella Ltd [2025], where claims directed solely to a heater element in a hair styling appliance failed for lack of support, as the specification did not enable the claimed breadth absent additional structural features. Finally, Seqirus Inc v Translate Bio Inc [2025] saw mRNA delivery system claims refused on the basis that they extended beyond the lipid ratios expressly disclosed, again illustrating that enablement requires that the specification actually teach the full scope of the claim.
In relation to written description/support, the leading authority remains Lockwood, where the Court made it clear that support is not merely a matter of linguistic consistency i.e., the breadth of the claim must be commensurate with the technical contribution disclosed.
The Australian Patent Manual of Practice and Procedure sets forth clear expectations for both enablement and written description. In assessing enablement, Examiners ask whether the specification, read in light of the common general knowledge, enables a skilled person to perform the entire invention without undue experimentation. They scrutinise for ambiguity, unnecessary reliance on trial-and-error, or unexplained omissions of essential parameters, each of which may indicate that the disclosure falls short. On the written description front, examiners examine whether the claims are genuinely supported by the embodiments and technical teaching in the specification, drawing a line under “armchair” claims, that is, claims that are drafted broadly without corresponding examples or structural support.
A range of common drafting missteps regularly trigger objections. A prevalent issue is overbroad generalisation i.e., claims that extend beyond the disclosed embodiments without offering a generic principle to underpin the broader coverage. Another frequent pitfall is the omission of critical implementation details, especially in fields such as biotechnology, pharmaceuticals, and AI, where precise formulation data, algorithm parameters, or operating conditions are essential for the skilled person to perform the invention. Equally problematic is the failure to enable the extremities of claim ranges, for instance, if a claim spans a parameter range, the specification must enable not only the central value but also the edge values, failing which enablement may be denied. Finally, a lack of integration between enablement requirements and the best method disclosure can leave the specification exposed to dual objections, jeopardising both sufficiency and legal validity.
To pre-empt these issues, strategic drafting is essential. The specification should present the invention through multiple embodiments, each explained in terms of the underlying principle or mechanism, ensuring that claim breadth is justified by actual technical teaching. Including working examples and experimental data, particularly in less predictable technical disciplines, fortifies the disclosure’s credibility. Where claims cover classes of compounds, devices, or processes, the specification must enable every member of that class without undue burden. Embedding the best method known at filing at the earliest drafting stage not only aligns with legal requirements but also avoids speculative gaps that cannot be filled later. Consistent terminology throughout the document is equally important, as inconsistencies may undermine clarity and support.
While the Australian statute is distinct, its doctrine is similar to statutory laws of other jurisdictions. The UK and New Zealand apply sufficiency and plausibility standards akin to Australia’s enablement and support tests. In the United States, 35 U.S.C. § 112(a) separates enablement and written description more formally, but the underlying principles, teaching and possession, remain consistent. However, Australia’s unique interpretation places primary weight on the capabilities of the person skilled in the art and the degree to which the claims are anchored in the technical contribution disclosed.
Ultimately, enablement and written description should not be treated as formal steps in the drafting process. These requirements strike at the heart of a patent’s robustness and enforceability. An application that fails either prong runs the risk of rejection during prosecution or revocation post-grant. By focusing on granular disclosure, technical depth, and claim-disclosure alignment, from statute to practice, patent applicants place themselves on solid legal footing under the demanding standards of IP Australia and the Federal Court.
Milind Joshi
Milind is a registered Patent and Trademarks Attorney in Australia, New Zealand, and India, bringing extensive expertise to our team.